Viral peptides remodel the tumor immune microenvironment of cold tumors with RNA-seq insights
Open Access
- 4 December 2025
- journal article
- Published by Elsevier in SLAS Technology
- Vol. 36, 100379
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82002775)
This publication has 29 references indexed in Scilit:
- Evolutionary conservation and positive selection of influenza A nucleoprotein CTL epitopes for universal vaccinationJournal of Medical Virology, 2022
- Redirecting host preexisting influenza A virus immunity for cancer immunotherapyCancer Immunology, Immunotherapy, 2021
- Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid TumorsCancer Cell, 2020
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responsesNature, 2020
- Top 10 Challenges in Cancer ImmunotherapyImmunity, 2020
- Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapyNature Communications, 2019
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapiesNature Reviews Drug Discovery, 2019
- Understanding the tumor immune microenvironment (TIME) for effective therapyNature Medicine, 2018
- Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapyCellular & Molecular Immunology, 2018
- Resistance to checkpoint blockade therapy through inactivation of antigen presentationNature Communications, 2017